(Q42427413)

31 October 2017

0 references

Multi-kinase inhibition in ovarian cancer (English)

1 reference

31 October 2017

1 reference

1

Paul Dent

1 reference

31 October 2017

18 October 2013

1 reference

Cancer Biology and Therapy

31 October 2017

1 reference

31 October 2017

15

1 reference

31 October 2017

1

1 reference

31 October 2017

1-2

1 reference

Two cases of recurrent ovarian clear cell carcinoma treated with sorafenib

31 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3938511

Clear cell cancer of the ovary

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3938511

28 May 2018

Regorafenib for cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3938511

VEGF/VEGFR pathway inhibitors as anti-angiogenic agents: present and future

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3938511

Activity of sorafenib in recurrent ovarian cancer and primary peritoneal carcinomatosis: a gynecologic oncology group trial

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3938511

Vorinostat and sorafenib increase CD95 activation in gastrointestinal tumor cells through a Ca(2+)-de novo ceramide-PP2A-reactive oxygen species-dependent signaling pathway

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3938511

Apoptosis induced by the kinase inhibitor BAY 43-9006 in human leukemia cells involves down-regulation of Mcl-1 through inhibition of translation

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3938511

Phase II study of sorafenib in patients with advanced hepatocellular carcinoma

28 May 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24309512

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.4161/CBT.26708

1 reference

31 October 2017

1 reference

PMC publication ID

3938511

31 October 2017

PubMed publication ID

24309512

1 reference

PMC publication ID

3938511